Latest Choksi Laboratories stock price
Choksi Laboratories P/E Ratio
CHOKSILA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
36.14
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
36.14
Current Price
₹96.00
EPS (TTM)
₹2.19
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
61.19
Sector Median
38.14
Sector Rank
#11 of 47
Sector Percentile
23.4%
Key P/E Ratio Insights for Choksi Laboratories
- Stock appears overvalued with PE of 36.14, suggesting caution for new investments
- Trading at discount to sector average PE of 61.19
View the CHOKSILA equity price for detailed stock performance.
Related Pages for Choksi Laboratories
Additional stock information and data for CHOKSILA
Sector P/E Ratio Comparison
Comparing Choksi Laboratories with other companies in Healthcare Services sector
Sector Average
61.19
Sector Median
38.14
Lowest P/E
7.08
Highest P/E
388.51
Companies
47
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 7.08 | ₹110 | Low |
| Nidan Labs & Healthcare | NIDAN | 10.92 | ₹22 | Low |
| Shanmuga Hospital | SHANMUGA | 11.99 | ₹50 | Low |
| Deccan Health Care | DECCAN | 13.5 | ₹31 | Low |
| Abate AS Industries | ABATEAS | 17.61 | ₹193 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.81 | ₹1,107 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 18.97 | ₹1,276 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 19.8 | ₹3,704 | Moderate |
| Asarfi Hospital | ASARFI | 19.86 | ₹317 | Moderate |
| Medinova Diagnostic Serv… | MEDINOV | 20.28 | ₹44 | Moderate |